36 /100
MEDIUM RISK
Score updated May 30, 2026

GLMD — Galmed Pharmaceuticals Ltd. Dilution Risk Tracker

Track GLMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLMD — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.62 below $1 exchange minimum
🔔 Track GLMD — Get forecast alerts →

💹 Market Data

Market Cap$4.97M
Shares Outstanding6.60M
Float6.37M
Cash$18.16M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 221.6K shares
#1 Two Sigma Investments, LP 112.1K shares
#2 Citadel Advisors Llc 38.2K shares
#3 Two Sigma Advisers, LP 31.5K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest57.6K
Days to Cover1.0
% of Float0.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2015
EFFECT EFFECT Apr 01, 2026
3 FORM3 Mar 18, 2026
3 FORM3 Mar 18, 2026
3 FORM3 Mar 18, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GLMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLMD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GLMD
📊 GLMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GLMD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.